# Botulinum Toxin A to Treat Arm Tremor

> **NCT02207946** · PHASE2 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 30 (actual)

## Conditions studied

- Essential Tremor of the Upper Limbs

## Interventions

- **DRUG:** IncobotulinumtoxinA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02207946
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-05
- **Primary completion:** 2016-05-09
- **Final completion:** 2016-09-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207946, "Botulinum Toxin A to Treat Arm Tremor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02207946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*